These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
595 related items for PubMed ID: 17444496
1. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. Korosi A, Kozicz T, Richter J, Veening JG, Olivier B, Roubos EW. J Comp Neurol; 2007 Jun 20; 502(6):973-89. PubMed ID: 17444496 [Abstract] [Full Text] [Related]
2. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Korosi A, Veening JG, Kozicz T, Henckens M, Dederen J, Groenink L, van der Gugten J, Olivier B, Roubos EW. Brain Res; 2006 Feb 09; 1072(1):46-54. PubMed ID: 16423327 [Abstract] [Full Text] [Related]
3. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland. Okada R, Miller MF, Yamamoto K, De Groef B, Denver RJ, Kikuyama S. Gen Comp Endocrinol; 2007 Feb 09; 150(3):437-44. PubMed ID: 17188689 [Abstract] [Full Text] [Related]
4. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions. Klose J, Fechner K, Beyermann M, Krause E, Wendt N, Bienert M, Rudolph R, Rothemund S. Biochemistry; 2005 Feb 08; 44(5):1614-23. PubMed ID: 15683245 [Abstract] [Full Text] [Related]
9. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF. J Pharmacol Exp Ther; 2004 Sep 08; 310(3):1027-34. PubMed ID: 15115804 [Abstract] [Full Text] [Related]
10. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system. Liu S, Gao X, Gao N, Wang X, Fang X, Hu HZ, Wang GD, Xia Y, Wood JD. J Comp Neurol; 2005 Jan 17; 481(3):284-98. PubMed ID: 15593376 [Abstract] [Full Text] [Related]
11. Urocortins and the regulation of gastrointestinal motor function and visceral pain. Martinez V, Wang L, Million M, Rivier J, Taché Y. Peptides; 2004 Oct 17; 25(10):1733-44. PubMed ID: 15476940 [Abstract] [Full Text] [Related]
17. Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain. Nijsen M, Ongenae N, Meulemans A, Coulie B. Neurogastroenterol Motil; 2005 Jun 17; 17(3):423-32. PubMed ID: 15916630 [Abstract] [Full Text] [Related]
18. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Hashimoto K, Nishiyama M, Tanaka Y, Noguchi T, Asaba K, Hossein PN, Nishioka T, Makino S. Peptides; 2004 Oct 17; 25(10):1711-21. PubMed ID: 15476938 [Abstract] [Full Text] [Related]
19. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats. Pintér D, Balangó B, Simon B, Palotai M, Csabafi K, Dobó É, Ibos KE, Bagosi Z. Neuropeptides; 2021 Aug 17; 88():102147. PubMed ID: 33932861 [Abstract] [Full Text] [Related]
20. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. Sánchez MM, Young LJ, Plotsky PM, Insel TR. J Comp Neurol; 1999 Jun 07; 408(3):365-77. PubMed ID: 10340512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]